Literature DB >> 22219010

Long-term results of ablation with antireflux surgery for Barrett's esophagus: a clinical and molecular biologic study.

Tuuli Kauttu1, Jari Räsänen, Leena Krogerus, Eero Sihvo, Pauli Puolakkainen, Jarmo A Salo.   

Abstract

BACKGROUND: The initial results from ablation therapy for metaplastic/dysplastic Barrett's esophagus (BE) are promising, but the results of extended follow-up evaluation are seldom reported.
METHODS: Neodymium:yttrium-aluminum-garnet laser ablation and successful antireflux surgery for 18 patients with metaplastic BE primarily resulted in the total histologic eradication of BE in 15 patients (83%). After antireflux surgery, the healing of gastroesophageal reflux disease (GERD) was objectively verified in all the patients. At late follow-up evaluation, endoscopy, conventional histology, molecular oxidative stress analyses in comparison with normal control conditions (8-hydroxydeoxyguanosine [8-OHdG], superoxide dismutase [SOD], glutathione [GSH], myeloperoxydase [MP]), and immunohistochemistry (p53, and Cdx2, caudal-related homeobox gene 2, marking intestinal differentiation) of the neosquamous epithelium were performed.
RESULTS: At the end of the follow-up period (range, 3-15 years; mean, 8 years), intestinal metaplasia without dysplasia was detected histologically in eight patients (44%). Six patients had macroscopic BE (mean length, 3.5 cm; range 1-10 cm). The neosquamous epithelium was histologically normal, with no underlying columnar tissue. The fundoplication was endoscopically normal in 14 patients (82%). The 8-OHdG level was higher in the neosquamous epithelium than in the control conditions in the distal esophagus (4.3 vs. 0.52; P = 0.0002) and the proximal esophagus (1.8 vs. 0.95; P = 0.006). Likewise, SOD activity was higher in the neosquamous epithelium (0.38 vs. 0.12; P = 0.0005), whereas MP activity and GSH levels remained normal. Three patients showed slight nuclear p53 expression (typical in normal inflammatory reactions), whereas Cdx2 positivity was confined to one case with recurrent intestinal metaplasia.
CONCLUSIONS: The neosquamous mucosa, generated by the ablation of BE and the treatment of GERD with fundoplication, was stable during long-term follow-up evaluation in two-thirds of the patients with initial eradication. It had normal p53 expression and no Cdx2 protein expression. The oxidative stress of the neosquamous esophagus remained high, although the clinical significance of this is unclear.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22219010     DOI: 10.1007/s00464-011-2121-3

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  26 in total

1.  Clinical significance of esophageal histologic findings after antireflux surgery.

Authors:  T K Rantanen; J T Salminen; J E Mäkinen; P I Sipponen; T A Kiviluoto; J A Salo
Journal:  Arch Surg       Date:  2001-07

2.  Randomized trial of argon plasma coagulation versus endoscopic surveillance for barrett esophagus after antireflux surgery: late results.

Authors:  Tim Bright; David I Watson; William Tam; Philip A Game; David Astill; Roger Ackroyd; Bas P L Wijnhoven; Peter G Devitt; Mark N Schoeman
Journal:  Ann Surg       Date:  2007-12       Impact factor: 12.969

3.  Properties of the neosquamous epithelium after radiofrequency ablation of Barrett's esophagus containing neoplasia.

Authors:  Roos E Pouw; Joep J Gondrie; Agnieszka M Rygiel; Carine M Sondermeijer; Fiebo J ten Kate; Robert D Odze; Michael Vieth; Kausilia K Krishnadath; Jacques J Bergman
Journal:  Am J Gastroenterol       Date:  2009-04-21       Impact factor: 10.864

4.  Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett's oesophagus.

Authors:  Katerina Dvorak; Claire M Payne; Melissa Chavarria; Lois Ramsey; Barbora Dvorakova; Harris Bernstein; Hana Holubec; Richard E Sampliner; Naihsuan Guy; Amanda Condon; Carol Bernstein; Sylvan B Green; Anil Prasad; Harinder S Garewal
Journal:  Gut       Date:  2006-12-04       Impact factor: 23.059

5.  Free radicals and antioxidant systems in reflux esophagitis and Barrett's esophagus.

Authors:  Pilar Jiménez; Elena Piazuelo; M Teresa Sánchez; Javier Ortego; Fernando Soteras; Angel Lanas
Journal:  World J Gastroenterol       Date:  2005-05-14       Impact factor: 5.742

6.  The impact of antireflux surgery on oxidative stress of esophageal mucosa caused by gastroesophageal reflux disease: 4-yr follow-up study.

Authors:  Tuomo K Rantanen; Jari V Räsänen; Eero I T Sihvo; Markku O Ahotupa; Martti A Färkkilä; Jarmo A Salo
Journal:  Am J Gastroenterol       Date:  2006-02       Impact factor: 10.864

7.  Mucosal reactive oxygen species production in oesophagitis and Barrett's oesophagus.

Authors:  M Olyaee; S Sontag; W Salman; T Schnell; S Mobarhan; D Eiznhamer; A Keshavarzian
Journal:  Gut       Date:  1995-08       Impact factor: 23.059

8.  KTP laser ablation of Barrett's esophagus after anti-reflux surgery results in long-term loss of intestinal metaplasia. Potassium-titanyl-phosphate.

Authors:  S P Bowers; S G Mattar; P J Waring; K Galloway; A Nasir; R Pascal; J G Hunter; S G Mattear
Journal:  Surg Endosc       Date:  2002-10-08       Impact factor: 4.584

9.  The expression of 8-hydroxydeoxyguanosine in oesophageal tissues and tumours.

Authors:  J V Räsänen; E I T Sihvo; M O Ahotupa; M A Färkkilä; J A Salo
Journal:  Eur J Surg Oncol       Date:  2007-04-30       Impact factor: 4.424

10.  Radiofrequency ablation in Barrett's esophagus with dysplasia.

Authors:  Nicholas J Shaheen; Prateek Sharma; Bergein F Overholt; Herbert C Wolfsen; Richard E Sampliner; Kenneth K Wang; Joseph A Galanko; Mary P Bronner; John R Goldblum; Ana E Bennett; Blair A Jobe; Glenn M Eisen; M Brian Fennerty; John G Hunter; David E Fleischer; Virender K Sharma; Robert H Hawes; Brenda J Hoffman; Richard I Rothstein; Stuart R Gordon; Hiroshi Mashimo; Kenneth J Chang; V Raman Muthusamy; Steven A Edmundowicz; Stuart J Spechler; Ali A Siddiqui; Rhonda F Souza; Anthony Infantolino; Gary W Falk; Michael B Kimmey; Ryan D Madanick; Amitabh Chak; Charles J Lightdale
Journal:  N Engl J Med       Date:  2009-05-28       Impact factor: 91.245

View more
  2 in total

1.  Nrf2 deficiency impairs the barrier function of mouse oesophageal epithelium.

Authors:  Hao Chen; Yuhui Hu; Yu Fang; Zorka Djukic; Masayuki Yamamoto; Nicholas J Shaheen; Roy C Orlando; Xiaoxin Chen
Journal:  Gut       Date:  2013-05-15       Impact factor: 23.059

Review 2.  Management strategies of Barrett's esophagus.

Authors:  Giovanni D De Palma
Journal:  World J Gastroenterol       Date:  2012-11-21       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.